Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2022

20-01-2022 | Thrombosis | Editorial

Anticoagulation Resumption After Colonic Polypectomy: Predicting Prime Post-procedural Timing

Authors: Natalia Causada Calo, Jeffrey Mosko

Published in: Digestive Diseases and Sciences | Issue 7/2022

Login to get access

Excerpt

Colonoscopic detection and removal of adenomas reduces colorectal cancer incidence and associated mortality [1]. Though colonoscopy is considered a safe procedure, it is associated with a risk of bleeding when polypectomy is performed. Though the risk of post-polypectomy bleeding (PPB) is 1% in patients without risk factors [2], it is 1.8–8% in patients receiving antiplatelet or anticoagulation therapy [3]. Other factors that can influence the risk of PPB include comorbidities such as renal and cardiovascular disease, polyp size and morphology, and polypectomy technique [4]. For instance, in patients requiring complex resections with techniques such as wide-field endoscopic mucosal resection, the risk of bleeding was reported to be 6.2%, with repeat colonoscopy required in half of the patients [5]. Importantly, the highest bleeding risk is present within 48 h of the initial polypectomy. …
Literature
4.
go back to reference Sawhney MS, Salfiti N, Nelson DB, Lederle FA, Bond JH. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 2008;75:115–119.CrossRef Sawhney MS, Salfiti N, Nelson DB, Lederle FA, Bond JH. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 2008;75:115–119.CrossRef
Metadata
Title
Anticoagulation Resumption After Colonic Polypectomy: Predicting Prime Post-procedural Timing
Authors
Natalia Causada Calo
Jeffrey Mosko
Publication date
20-01-2022
Publisher
Springer US
Keyword
Thrombosis
Published in
Digestive Diseases and Sciences / Issue 7/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07349-9

Other articles of this Issue 7/2022

Digestive Diseases and Sciences 7/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.